Rigel Pharmaceuticals, Inc.
(RIGL - NASDAQ)
30,51 USD
📋 Profilo Aziendale

Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases.

|